Literature Collection

Collection Insights

11K+

References

9K+

Articles

1400+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Year
Sort by
Order
Show
11233 Results
11101
What is the role of consultation-liaison psychiatry in the management of depression in primary care? A systematic review and meta-analysis
Type: Journal Article
Authors: John Cape, Craig Whittington, Peter Bower
Year: 2010
Publication Place: Netherlands: Elsevier Science
Topic(s):
Education & Workforce See topic collection
11102
What is Zero Suicide?
Type: Web Resource
Authors: National Action Alliance for Suicide Prevention
Year: 2014
Topic(s):
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

11103
What It Will Take To Achieve The As-Yet-Unfulfilled Promises Of Health Information Technology
Type: Journal Article
Authors: A. L. Kellermann, S. S. Jones
Year: 2013
Topic(s):
HIT & Telehealth See topic collection
11104
What more do we need to know about medication-assisted treatment for prescription opioid abusers?
Type: Journal Article
Authors: Stephen Magura
Year: 2009
Topic(s):
Opioids & Substance Use See topic collection
11105
What now?: Experiences of VHA patients following disclosure of suicidal ideation in primary care and mental health settings
Type: Journal Article
Authors: Summer Newell, Annabelle Rynerson, Praful Gade, Nazanin H. Bahraini, Lauren M. Denneson, Steven K. Dobscha
Year: 2024
Topic(s):
Healthcare Disparities See topic collection
,
Education & Workforce See topic collection
11107
What primary care psychology has to offer the Patient-Centered Medical Home
Type: Journal Article
Authors: Susan H. McDaniel, Colleen T. Fogarty
Year: 2009
Publication Place: United States
Topic(s):
Medical Home See topic collection
11109
What The Evidence Shows About Patient Activation: Better Health Outcomes And Care Experiences; Fewer Data On Costs
Type: Journal Article
Authors: J. H. Hibbard, J. Greene
Year: 2013
Topic(s):
Financing & Sustainability See topic collection
11110
What to do when evidence-based treatment manuals are not enough? Adapting evidence-based psychological interventions for primary care
Type: Journal Article
Authors: Craig N. Sawchuk, Hannah Mulholland, Sarah Trane, Jocelyn R. Lebow, Ajeng Puspitasari, Nathaniel Lombardi
Year: 2020
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
11111
What to Expect With Pregnant or Postpartum Prescribing of Extended-Release Buprenorphine (CAM2038)
Type: Journal Article
Authors: M. R. Lofwall, J. L. Young, Z. Hansen, E. M. Wachman, C. Wilder, C. Guille, J. E. Charles, L. Leeman, J. R. Gray, T. J. Winhusen
Year: 2023
Abstract:

Weekly and monthly CAM2038 (Brixadi(®)) extended-release subcutaneous buprenorphine (XR bup) has been available in Europe and Australia for several years and was approved by the Food and Drug Administration in May 2023. Little is known about the clinical experience of patients and providers using this new medication during prenatal care. Two cases of pregnant persons with opioid use disorder receiving weekly XR bup in an ongoing randomized multi-site outpatient clinical trial are presented along with a brief review of the pharmacology and literature on XR bup formulations. The cases in pregnancy illustrate how treatment with the weekly formulation is initiated including how to make dose adjustments, which may be necessary given the longer half-life; it takes 1 month to achieve steady state. Injection site pain with medication administration was time limited and managed readily. Other injection site reactions experienced included subcutaneous erythema and induration that was delayed in onset and typically mild, resolving with minimal intervention. Delivery management and breastfeeding recommendations while on weekly XR bup were not different compared to sublingual buprenorphine (SL bup). Weekly XR bup is a new treatment for opioid use disorder that may be used in the obstetric population. Obstetric and addiction medicine clinicians should be aware of this new formulation as its use is expected to increase.

Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Education & Workforce See topic collection
11112
What we need to know about behavioral health and psychology in the patient-centered medical home
Type: Journal Article
Authors: Rodger Kessler
Year: 2010
Publication Place: United Kingdom: Wiley-Blackwell Publishing Ltd.
Topic(s):
Medical Home See topic collection
11113
What work has to be done to implement collaborative care for depression? Process evaluation of a trial utilizing the Normalization Process Model
Type: Journal Article
Authors: L. Gask, P. Bower, K. Lovell, D. Escott, J. Archer, S. Gilbody, A. J. Lankshear, A. E. Simpson, D. A. Richards
Year: 2010
Publication Place: England
Abstract: BACKGROUND: There is a considerable evidence base for 'collaborative care' as a method to improve quality of care for depression, but an acknowledged gap between efficacy and implementation. This study utilises the Normalisation Process Model (NPM) to inform the process of implementation of collaborative care in both a future full-scale trial, and the wider health economy. METHODS: Application of the NPM to qualitative data collected in both focus groups and one-to-one interviews before and after an exploratory randomised controlled trial of a collaborative model of care for depression. RESULTS: Findings are presented as they relate to the four factors of the NPM (interactional workability, relational integration, skill-set workability, and contextual integration) and a number of necessary tasks are identified. Using the model, it was possible to observe that predictions about necessary work to implement collaborative care that could be made from analysis of the pre-trial data relating to the four different factors of the NPM were indeed borne out in the post-trial data. However, additional insights were gained from the post-trial interview participants who, unlike those interviewed before the trial, had direct experience of a novel intervention. The professional freedom enjoyed by more senior mental health workers may work both for and against normalisation of collaborative care as those who wish to adopt new ways of working have the freedom to change their practice but are not obliged to do so. CONCLUSIONS: The NPM provides a useful structure for both guiding and analysing the process by which an intervention is optimized for testing in a larger scale trial or for subsequent full-scale implementation.
Topic(s):
General Literature See topic collection
11114
What works in managing complex conditions in older people in primary and community care? A state‐of‐the‐art review
Type: Journal Article
Authors: Rachael Frost, Greta Rait, Alison Wheatley, Jane Wilcock, Louise Robinson, Karen Harrison Dening, Louise Allan, Sube Banerjee, Jill Manthorpe, Kate Walters
Year: 2020
Publication Place: Oxford
Topic(s):
Healthcare Disparities See topic collection
11115
What's known about implementing co-located paediatric integrated care: a scoping review
Type: Journal Article
Authors: Rheanna E. Platt, Andrea E. Spencer, Matthew D. Burkey, Carol Vidal, Sarah Polk, Amie F. Bettencourt, Sonal Jain, Julia Stratton, Lawrence S. Wissow
Year: 2018
Publication Place: Oxfordshire
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
11116
When a usual source of care and usual provider matter: Adult prevention and screening services
Type: Journal Article
Authors: Lynn A. Blewett, Pamela Jo Johnson, Brian Lee, Peter B. Scal
Year: 2008
Publication Place: Germany: Springer
Topic(s):
Medical Home See topic collection
11117
When and How Do Brief Alcohol Interventions in Primary Care Reduce Alcohol Use and Alcohol-Related Consequences among Adolescents?
Type: Journal Article
Authors: A. S. Newton, C. Mushquash, M. Krank, T. C. Wild, M. P. Dyson, L. Hartling, S. H. Stewart
Year: 2018
Publication Place: United States
Topic(s):
Opioids & Substance Use See topic collection
11118
When Are Prescribers Required to Use Prescription Drug Monitoring Programs?
Type: Report
Authors: The Pew Charitable Trusts
Year: 2018
Publication Place: Washington, DC
Topic(s):
Grey Literature See topic collection
,
Healthcare Policy See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

11119
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis
Type: Journal Article
Authors: W. C. Becker, D. A. Fiellin
Year: 2020
Abstract:

COVID-19 could cause infection in persons with opioid use disorder, increase opioid overdose rates, reverse system-level gains in expanding access to medication for opioid use disorder, halt critical research, and prevent exacting legal reparations against opioid manufacturers. The authors call for urgent action to counteract these risks.

Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
11120
When higher doses in opioid replacement treatment are still inadequate - association to multidimensional illness severity: a cohort study
Type: Journal Article
Authors: J. Reimer, E. Boniakowski, C. Bachner, B. Weber, W. Tietje, U. Verthein, S. Walcher
Year: 2014
Publication Place: England
Abstract: BACKGROUND: Opioid replacement treatment (ORT) with methadone is regarded as gold standard in the treatment of opioid addiction. Treatment doses of 60 mg methadone per day and above are associated with better treatment retention and reduction in the use of heroin and cocaine. However, an absolute dose level cannot function as parameter for adequate dosing. This study aims to determine dose adequacy in a sample of patients on stable methadone treatment, and to relate dose adequacy to disease severity. METHODS: This study was designed as open prospective cohort study over 12 months, with baseline data reported here. Patients on stable substitution treatment with methadone (Eptadone(R)) were consecutively included. Medical and socio-demographic data were gathered and the instruments Opiate Dosage Adequacy Scale (ODAS), European Addiction Severity Index (EuropASI) and the Derogatis Interview for Sexual Functioning - Self Report (DISF-SR) were applied. RESULTS: Five hundred and sixteen subjects, who received on average 60.3 (+/-30.4) mg methadone per day, were included. According to ODAS, 40.6% suffered from an inadequate dosing, and 59.4% had an adequate dose. Patients with an adequate dose received on average 57.8 (+/-27.5) mg methadone per day, whilst patients with an inadequate dose received on average 70.6 (+/-33.0) mg per day. The frequencies of patients with methadone doses of less than 60 mg per were 45.4% in the inadequate and 60.6% in the adequate group. The inadequate group suffered from a statistically significant higher burden of addiction related problems in all EuropASI domains. Sexual functioning did not differ by adequacy group, but women suffered from more pronounced sexual dysfunction as compared to men. CONCLUSION: A high frequency of inadequate dosing was found in this sample of patients on ORT. Higher disease severity should alert for possible need of even higher methadone doses. The tendency to low methadone doses warrants further research in the treatment system. Higher methadone doses are not related to increased sexual dysfunction. Sexual dysfunction, especially in women, should be considered in treatment.
Topic(s):
Opioids & Substance Use See topic collection